Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004580116 | SCV005062624 | likely pathogenic | Hypertrophic cardiomyopathy | 2019-04-22 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). This variant has not been reported in the literature in individuals with MYBPC3-related conditions. This variant is a deletion of the genomic region encompassing exons 13-25 and part of exon 12 (c.1037_2602+186del) of the MYBPC3 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |